Reimagining Risk and Resilience
By Stephanie Harden, Tracy Hibbs
May 29, 2026
Accelerating analytical data management for the next-generation laboratory
7 min read
False
Advertisement
Business Practice
The Real Reason Shadow AI Is Spreading
By Sean Blake
May 12, 2026
When lab tools fail to support interpretation and decision-making, scientists find alternatives
3 min read
This Week’s Biopharma News: RFK Jr Selects New Members for US Vaccine Committee
June 19, 2025
Our latest news roundup reports on a new RSV FDA approval for Moderna, payment hikes in the UK, and calls in the US for a ban on direct-to-consumer advertising.
4 min read
This Week’s Biopharma News: Argentina’s WHO Exit and Sanofi Acquisition of Blueprint Medicines
By Rob Coker
June 6, 2025
Our latest news roundup reports on Novartis’ prostate cancer trial, Sandoz’ osteoporosis biosimilars, and more.
4 min read
AI or Tradition: The Great Pharma Sales Dilemma
June 3, 2025
Pharma sales teams are under pressure, but traditional training models aren’t keeping up. Can AI help?
3 min read
This Week’s Biopharma News: Pfizer and Astellas Drug Improves Cancer Survival
By Rob Coker
May 30, 2025
Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.
4 min read
Behind the Scenes of a GMP Win
May 29, 2025
We ask a company about lessons learned from the GMP certification process.
4 min read
The New Age of Global, Political, and Regulatory Challenges
May 28, 2025
A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in – and unique to – the pharmaceutical industry, from supply chains to tariffs, and more.
7 min read
What Trump’s Latest Moves Mean for the Industry
May 27, 2025
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
6 min read
This Week’s Industry News: Changes at the top of Novo Nordisk
May 22, 2025
Our latest news roundup reports on changes at Novo Nordisk, AbbVie’s ADC accelerated approval, Regeneron’s new acquisition, and more.
3 min read
